Cen Biotech

(OTC) CENBF

Current Price$0.00

Market Cap$6.40K

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Cen Biotech Financials at a Glance

Market Cap

$6.40K

Revenue (TTM)

$619.83K

Net Income (TTM)

-$741.54K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

56.38 (High)

Dividend

$0.00

Beta (Volatility)

56.38 (High)

Price

$0.00

Volume

2,113

Open

$0.00

Price

$0.00

Volume

2,113

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2023

Dividend

$0.00

Beta (Volatility)

56.38 (High)

Price

$0.00

Volume

2,113

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2023

CENBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cen Biotech

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Brian S. Payne

Website

www.cenbiotechinc.com

Headquarters

Windsor, ON N8T 3R9, CA

CENBF Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

Return on Capital

60%

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.40K

Shares Outstanding

64.13M

Volume

2.11K

Avg. Volume

281.609

Financials (TTM)

Gross Profit

$498.00K

Operating Income

-$1.27M

EBITDA

-$773.00K

Operating Cash Flow

-$335.50K

Capital Expenditure

-$129.53K

Free Cash Flow

-$465.04K

Cash & ST Invst.

$83.60K

Total Debt

$5.23M

Cen Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$65.23K

-52.0%

Gross Profit

$65.23K

+200.3%

Gross Margin

100.00%

N/A

Market Cap

$6.40K

N/A

Market Cap/Employee

$1.60K

N/A

Employees

N/A

Net Income

$371.46K

+192.9%

EBITDA

$409.91K

+356.0%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$419.60K

+183.2%

Total Debt

$4.98M

+270.6%

Accounts Receivable

$114.74K

+151.3%

Inventory

$0.00

N/A

Long Term Debt

$121.87K

-35.9%

Short Term Debt

$4.85M

+321.2%

Return on Assets

-19.28%

N/A

Return on Invested Capital

59.82%

N/A

Free Cash Flow

$396.81K

+540.2%

Operating Cash Flow

$432.12K

+579.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BLMSBloomios, Inc.

BLMSBloomios, Inc.$0.00+0.00%

WOWUWOWI, Inc.

WOWUWOWI, Inc.$0.00+0.00%

SESISES Solar Inc.

SESISES Solar Inc.$0.00+0.00%

VIVXFAvivagen Inc.

VIVXFAvivagen Inc.$0.00+0.00%

UPPRUpper Street Marketing Inc.

UPPRUpper Street Marketing Inc.$0.00+0.00%

SPLMSentry Petroleum Ltd

SPLMSentry Petroleum Ltd$0.00+0.00%

MJNEMJ Holdings, Inc.

MJNEMJ Holdings, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PAYOPayoneer Global

PAYOPayoneer Global$7.03+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.92+0.02%

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$8.50+1.14%

POETPoet Technologies

POETPoet Technologies$14.66+0.17%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$7.59-0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$188.66+0.17%

NOKNokia

NOKNokia$14.82+0.00%

Questions About CENBF

What is the current price of Cen Biotech?

Cen Biotech is trading at $0.00 per share.

What is the 52-week range for Cen Biotech?

Over the past 52 weeks, Cen Biotech has traded between $0.00 and $0.00.

How much debt does Cen Biotech have?

As of the most recent reporting period, Cen Biotech reported total debt of $5.23M.

How much cash does Cen Biotech have on hand?

Cen Biotech reported $83.60K in cash and cash equivalents in its most recent financial results.

What is Cen Biotech’s dividend yield?

Cen Biotech does not currently have a dividend yield.

Cen Biotech

Cen Biotech Financials at a Glance

CENBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cen Biotech

CENBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cen Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CENBF

What is the current price of Cen Biotech?

What is the 52-week range for Cen Biotech?

How much debt does Cen Biotech have?

How much cash does Cen Biotech have on hand?

What is Cen Biotech’s dividend yield?

Premium Investing Services